CR Medical Holdings Partners with Shanghai Haohai Bio in Medical Aesthetics Sector
China Resources Medical Holdings Company Limited has entered into a strategic partnership with Shanghai Haohai...
Biotech
Brii Biosciences Licenses BRII-693 to Joincare Pharma for Development in Greater China
China-based Brii Biosciences Ltd (HKG: 2137) announced a licensing agreement with compatriot firm Joincare Pharmaceutical...
Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein
Shanghai-based Fosun Pharmaceutical (Group) Co., Ltd (HKG: 2196, SHA: 600196) has entered into a licensing...
Boehringer Ingelheim and Echosens Expand Partnership to Tackle MASH
Germany-based Boehringer Ingelheim and France-based Echosens have expanded their partnership to enhance early screening, precise...
Qure Biotechnology Secures RMB 100 Million Series C1 Financing
China-based Qure Biotechnology (Shanghai) Co., Ltd. announced the completion of a Series C1 financing round...
Sichuan Kelun-Biotech Raises $250M in Hong Kong’s Largest Follow-On Offering
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) announced the successful placement of 5,918,000 new...
Sanofi to Acquire Blueprint Medicines for $9.1 Billion to Expand Rare Disease Pipeline
French pharmaceutical giant Sanofi (NASDAQ: SNY) announced plans to acquire US-based Blueprint Medicines Corporation for...
LongBio Pharma Secures RMB 200 Million Series C Funding for Clinical Studies
China-based LongBio Pharma, a developer of biomacromolecule drugs, has reportedly raised over RMB 200 million...
Neowise Biotech Licenses TCR Molecule to BeOne Medicines for Next-Gen Cell Therapy
Suzhou-based Neowise Biotechnology, a specialist in T Cell Receptor (TCR)-based therapies for solid tumors, announced...
Eli Lilly to Acquire SiteOne Therapeutics for Up to USD 1 Billion
US-based pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) announced plans to acquire compatriot biotech...
BeiGene Rebrands to BeOne Medicines and Relocates to Switzerland
BeiGene (NASDAQ: ONC, HKG: 6160, SHA: 688235), a global oncology company, has officially rebranded to...
Sichuan Kelun-Biotech Finalizes Licensing Deal for TSLP Monoclonal Antibody
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) announced that it has received the upfront...
Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation
China-based Shandong Boan Biotechnology Co., Ltd (HKG: 6955) has entered into a partnership with the...
Guangzhou Regenverse Therapeutics Raises RMB 100 Million in Pre-Series A Financing
China-based Guangzhou Regenverse Therapeutics Co., Ltd (former name: Guangzhou Regen Therapeutics Co., Ltd.), a developer...
LTZ Therapeutics Secures $40M Series A+ to Advance Immunotherapy Pipeline
Shenzhen-based LTZ Therapeutics has reportedly raised USD 40 million in a Series A+ financing round...
Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics
German pharmaceutical major Merck KGaA (ETR: MRK) is reportedly nearing the completion of its acquisition of...
Shineco Inc. Announces Acquisition of InfiniClone for Regenerative Medicine Expansion
US-based Shineco Inc. (NASDAQ: SISI) announced that its subsidiary Shineco Life Sciences Group Hong Kong...
Boehringer Ingelheim Partners with Tessellate Bio on ALT Cancer Therapies
Boehringer Ingelheim (BI), a German pharmaceutical leader, has entered into a strategic collaboration and global...
Johnson & Johnson Reports Q1 2025 Revenue Growth, Led by Innovative Medicines and MedTech
US pharmaceutical giant Johnson & Johnson (J&J, NYSE: JNJ) reported Q1 2025 revenues of USD...
RemeGen’s 2024 Revenue Soars 58.54% on Strong Product Sales and R&D Growth
China-based biotech RemeGen Co., Ltd (HKG: 9995, SHA: 688331) released its 2024 financial report, recording...